UFF
GMED icon

USA Financial Formulas’s Globus Medical GMED Stock Holding History

USA Financial Formulas’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$431 Buy
+5
New +$449 ﹤0.01% 404

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

USA Financial Formulas's GMED Position: Q1 2026 in Review

USA Financial Formulas opened a new position in Globus Medical (GMED) in Q1 2026: 5 shares worth $431. The stake represents ﹤0.01% of the portfolio and ranks #404 among its holdings.

602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • USA Financial Formulas held 5 shares of Globus Medical worth $431 as of Q1 2026.
  • Globus Medical was a new USA Financial Formulas position in Q1 2026.
  • Globus Medical made up ﹤0.01% of USA Financial Formulas's portfolio in Q1 2026, its #404 holding.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.